Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 1
2008 1
2011 1
2012 1
2013 1
2014 5
2015 5
2016 5
2017 6
2018 6
2019 6
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations.
Thrippleton MJ, Backes WH, Sourbron S, Ingrisch M, van Osch MJP, Dichgans M, Fazekas F, Ropele S, Frayne R, van Oostenbrugge RJ, Smith EE, Wardlaw JM. Thrippleton MJ, et al. Alzheimers Dement. 2019 Jun;15(6):840-858. doi: 10.1016/j.jalz.2019.01.013. Epub 2019 Apr 25. Alzheimers Dement. 2019. PMID: 31031101 Free PMC article. Review.
Cerebral blood flow in small vessel disease: A systematic review and meta-analysis.
Shi Y, Thrippleton MJ, Makin SD, Marshall I, Geerlings MI, de Craen AJM, van Buchem MA, Wardlaw JM. Shi Y, et al. Among authors: Thrippleton MJ. J Cereb Blood Flow Metab. 2016 Oct;36(10):1653-1667. doi: 10.1177/0271678X16662891. Epub 2016 Aug 5. J Cereb Blood Flow Metab. 2016. PMID: 27496552 Free PMC article. Review.
Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration.
Smith EE, Biessels GJ, De Guio F, de Leeuw FE, Duchesne S, Düring M, Frayne R, Ikram MA, Jouvent E, MacIntosh BJ, Thrippleton MJ, Vernooij MW, Adams H, Backes WH, Ballerini L, Black SE, Chen C, Corriveau R, DeCarli C, Greenberg SM, Gurol ME, Ingrisch M, Job D, Lam BYK, Launer LJ, Linn J, McCreary CR, Mok VCT, Pantoni L, Pike GB, Ramirez J, Reijmer YD, Romero JR, Ropele S, Rost NS, Sachdev PS, Scott CJM, Seshadri S, Sharma M, Sourbron S, Steketee RME, Swartz RH, van Oostenbrugge R, van Osch M, van Rooden S, Viswanathan A, Werring D, Dichgans M, Wardlaw JM. Smith EE, et al. Among authors: Thrippleton MJ. Alzheimers Dement (Amst). 2019 Feb 26;11:191-204. doi: 10.1016/j.dadm.2019.01.002. eCollection 2019 Dec. Alzheimers Dement (Amst). 2019. PMID: 30859119 Free PMC article. Review.
Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination.
Blair GW, Appleton JP, Law ZK, Doubal F, Flaherty K, Dooley R, Shuler K, Richardson C, Hamilton I, Shi Y, Stringer M, Boyd J, Thrippleton MJ, Sprigg N, Bath PM, Wardlaw JM. Blair GW, et al. Among authors: Thrippleton MJ. Int J Stroke. 2018 Jul;13(5):530-538. doi: 10.1177/1747493017731947. Epub 2017 Sep 14. Int J Stroke. 2018. PMID: 28906205 Clinical Trial.
Advanced Neuroimaging of Cerebral Small Vessel Disease.
Blair GW, Hernandez MV, Thrippleton MJ, Doubal FN, Wardlaw JM. Blair GW, et al. Among authors: Thrippleton MJ. Curr Treat Options Cardiovasc Med. 2017 Jul;19(7):56. doi: 10.1007/s11936-017-0555-1. Curr Treat Options Cardiovasc Med. 2017. PMID: 28620783 Free PMC article. Review.
Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial.
Blair GW, Appleton JP, Flaherty K, Doubal F, Sprigg N, Dooley R, Richardson C, Hamilton I, Law ZK, Shi Y, Stringer MS, Thrippleton MJ, Boyd J, Shuler K, Bath PM, Wardlaw JM. Blair GW, et al. Among authors: Thrippleton MJ. EClinicalMedicine. 2019 Apr 24;11:34-43. doi: 10.1016/j.eclinm.2019.04.001. eCollection 2019 May-Jun. EClinicalMedicine. 2019. PMID: 31317131 Free PMC article.
MRI measurement of blood-brain barrier leakage: minding the gaps.
Thrippleton MJ. Thrippleton MJ. J Physiol. 2019 Feb;597(3):667-668. doi: 10.1113/JP277425. Epub 2018 Dec 25. J Physiol. 2019. PMID: 30520035 Free PMC article. No abstract available.
Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study.
Marshall I, Thrippleton MJ, Bastin ME, Mollison D, Dickie DA, Chappell FM, Semple SIK, Cooper A, Pavitt S, Giovannoni G, Wheeler-Kingshott CAMG, Solanky BS, Weir CJ, Stallard N, Hawkins C, Sharrack B, Chataway J, Connick P, Chandran S; MS-SMART Trialists. Marshall I, et al. Among authors: Thrippleton MJ. J Neurol. 2018 Aug;265(8):1795-1802. doi: 10.1007/s00415-018-8903-y. Epub 2018 May 30. J Neurol. 2018. PMID: 29846780 Free PMC article. Clinical Trial.
38 results
Jump to page
Feedback